EP1040837A3
(en)
*
|
1999-02-26 |
2002-01-02 |
Erasmus Universiteit Rotterdam |
Medicaments for the treatment of a choroidal neovascularization (CNV) related disorder
|
DE60037406T2
(de)
|
1999-04-26 |
2008-05-21 |
GMP Vision Solutions, Inc., Ft. Lauderdale |
Aufblasbare vorrichtung zur behandlung von glaukoma
|
US6416777B1
(en)
*
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
US20050119737A1
(en)
*
|
2000-01-12 |
2005-06-02 |
Bene Eric A. |
Ocular implant and methods for making and using same
|
US6638239B1
(en)
|
2000-04-14 |
2003-10-28 |
Glaukos Corporation |
Apparatus and method for treating glaucoma
|
US20020143284A1
(en)
*
|
2001-04-03 |
2002-10-03 |
Hosheng Tu |
Drug-releasing trabecular implant for glaucoma treatment
|
US7867186B2
(en)
|
2002-04-08 |
2011-01-11 |
Glaukos Corporation |
Devices and methods for treatment of ocular disorders
|
US7708711B2
(en)
|
2000-04-14 |
2010-05-04 |
Glaukos Corporation |
Ocular implant with therapeutic agents and methods thereof
|
AR030346A1
(es)
|
2000-08-14 |
2003-08-20 |
Alcon Inc |
Metodo de tratamiento de desordenes neurodegenerativos de la retina y cabeza de nervio optico
|
AR030345A1
(es)
*
|
2000-08-14 |
2003-08-20 |
Alcon Inc |
Metodo de tratamiento de desordenes relacionados con angiogenesis
|
US7181287B2
(en)
*
|
2001-02-13 |
2007-02-20 |
Second Sight Medical Products, Inc. |
Implantable drug delivery device
|
WO2002078681A2
(en)
*
|
2001-04-02 |
2002-10-10 |
Alcon, Inc. |
Method of treating ocular inflammatory and angiogenesis-related disorders using an amide derivative of flubiprofen or ketorolac
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
US7488303B1
(en)
*
|
2002-09-21 |
2009-02-10 |
Glaukos Corporation |
Ocular implant with anchor and multiple openings
|
CA2683224C
(en)
|
2001-04-07 |
2014-12-02 |
Glaukos Corporation |
System and methods thereof for treatment of ocular disorders
|
US7678065B2
(en)
|
2001-05-02 |
2010-03-16 |
Glaukos Corporation |
Implant with intraocular pressure sensor for glaucoma treatment
|
US7094225B2
(en)
|
2001-05-03 |
2006-08-22 |
Glaukos Corporation |
Medical device and methods of use of glaucoma treatment
|
JP4677538B2
(ja)
|
2001-06-12 |
2011-04-27 |
ジョンズ ホプキンズ ユニヴァーシティ スクール オヴ メディシン |
眼内薬物送達のためのリザーバデバイス
|
CA2446741C
(en)
*
|
2001-07-23 |
2009-09-29 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
CA2447802C
(en)
|
2001-07-23 |
2009-09-29 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
US7331984B2
(en)
|
2001-08-28 |
2008-02-19 |
Glaukos Corporation |
Glaucoma stent for treating glaucoma and methods of use
|
ES2393101T3
(es)
*
|
2001-08-29 |
2012-12-18 |
Ricardo A. P. De Carvalho |
Sistema implantable y sellable para la administración unidireccional de agentes terapéuticos a tejidos diana
|
US7749528B2
(en)
*
|
2001-08-29 |
2010-07-06 |
Ricardo Azevedo Pontes De Carvalho |
Implantable and sealable medical device for unidirectional delivery of therapeutic agents to tissues
|
US7186232B1
(en)
|
2002-03-07 |
2007-03-06 |
Glaukoa Corporation |
Fluid infusion methods for glaucoma treatment
|
AU2003218127B2
(en)
*
|
2002-03-11 |
2007-07-12 |
Alcon, Inc. |
Implantable drug delivery system
|
US7951155B2
(en)
|
2002-03-15 |
2011-05-31 |
Glaukos Corporation |
Combined treatment for cataract and glaucoma treatment
|
US9301875B2
(en)
|
2002-04-08 |
2016-04-05 |
Glaukos Corporation |
Ocular disorder treatment implants with multiple opening
|
PL373787A1
(en)
*
|
2002-05-03 |
2005-09-19 |
Alcon Inc. |
Method of treating vascular endothelial growth factor mediated vascular disorders using amfenac or nepafenac
|
AU2003281817A1
(en)
*
|
2002-08-05 |
2004-02-23 |
Alcon, Inc. |
Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration
|
DE10238310A1
(de)
*
|
2002-08-21 |
2004-03-04 |
Erich Jaeger Gmbh |
Elektrodenanordnung
|
CA2498489C
(en)
*
|
2002-09-29 |
2010-02-23 |
Surmodics, Inc. |
Method for subretinal administration of therapeutics including steroids;method for localizing pharmacodynamic action at the choroid and the retina; and related methods for treatment and/or prevention of retinal diseases
|
US20030187072A1
(en)
*
|
2003-02-14 |
2003-10-02 |
Kapin Michael A. |
Method of treating angiogenesis-related disorders
|
PL378209A1
(pl)
*
|
2003-02-20 |
2006-03-20 |
Alcon, Inc. |
Formulacje glikokortykoidów do leczenia patologicznej angiogenezy w gałce ocznej
|
US20060154910A1
(en)
*
|
2003-02-20 |
2006-07-13 |
Bingaman David P |
Use of steroids to treat ocular disorders
|
US20040236343A1
(en)
*
|
2003-05-23 |
2004-11-25 |
Taylor Jon B. |
Insertion tool for ocular implant and method for using same
|
KR20060019579A
(ko)
*
|
2003-06-13 |
2006-03-03 |
알콘, 인코퍼레이티드 |
병적 눈 혈관형성을 치료하기 위한 비-스테로이드성항-염증제 제제
|
WO2004112796A1
(en)
*
|
2003-06-20 |
2004-12-29 |
Alcon, Inc. |
Treatment of amd with combination of ingredients
|
ZA200508654B
(en)
*
|
2003-07-10 |
2007-01-31 |
Alcon Inc |
Ophthalmic drug delivery device
|
US20050009910A1
(en)
*
|
2003-07-10 |
2005-01-13 |
Allergan, Inc. |
Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug
|
US8167855B2
(en)
*
|
2003-08-26 |
2012-05-01 |
Vista Scientific Llc |
Ocular drug delivery device
|
KR20060085246A
(ko)
|
2003-09-18 |
2006-07-26 |
마커사이트, 인코포레이티드 |
경공막 전달
|
US20050158365A1
(en)
*
|
2003-12-22 |
2005-07-21 |
David Watson |
Drug delivery device with mechanical locking mechanism
|
US7276050B2
(en)
*
|
2004-03-02 |
2007-10-02 |
Alan Franklin |
Trans-scleral drug delivery method and apparatus
|
US9549895B2
(en)
*
|
2004-04-23 |
2017-01-24 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving the viability of photoreceptor cells
|
US20060110428A1
(en)
|
2004-07-02 |
2006-05-25 |
Eugene Dejuan |
Methods and devices for the treatment of ocular conditions
|
US7722669B2
(en)
*
|
2004-08-13 |
2010-05-25 |
Richard Foulkes |
Method and insert for modifying eye color
|
US8246569B1
(en)
|
2004-08-17 |
2012-08-21 |
California Institute Of Technology |
Implantable intraocular pressure drain
|
CN100428958C
(zh)
*
|
2004-09-06 |
2008-10-29 |
段亚东 |
一种治疗眼病的植入剂
|
AU2006213588B2
(en)
*
|
2005-02-09 |
2011-11-17 |
Santen Pharmaceutical Co., Ltd. |
Liquid formulations for treatment of diseases or conditions
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
BRPI0609432A2
(pt)
*
|
2005-03-21 |
2010-04-06 |
Macusight Inc |
sistemas de distribuição de fármacos para tratamento de doenças ou condições
|
WO2006110487A1
(en)
|
2005-04-08 |
2006-10-19 |
Surmodics, Inc. |
Sustained release implants for subretinal delivery
|
US20060258994A1
(en)
*
|
2005-05-12 |
2006-11-16 |
Avery Robert L |
Implantable delivery device for administering pharmacological agents to an internal portion of a body
|
JP2009502954A
(ja)
|
2005-07-27 |
2009-01-29 |
ユニバーシティ オブ フロリダ リサーチ ファウンデーション,インコーポレイティド |
タンパク質のミスフォールディングを修正する小分子及びその使用
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
US20070134244A1
(en)
*
|
2005-10-14 |
2007-06-14 |
Alcon, Inc. |
Combination treatment for pathologic ocular angiogenesis
|
WO2007064752A2
(en)
|
2005-11-29 |
2007-06-07 |
Smithkline Beecham Corporation |
Treatment of ocular neovascular disorders such as macular degeneration, angiod streaks, uveitis and macular edema
|
US8492400B2
(en)
*
|
2006-02-09 |
2013-07-23 |
Santen Pharmaceutical Co., Ltd. |
Stable formulations, and methods of their preparation and use
|
US7887508B2
(en)
*
|
2006-03-14 |
2011-02-15 |
The University Of Southern California |
MEMS device and method for delivery of therapeutic agents
|
CN103127100A
(zh)
|
2006-03-23 |
2013-06-05 |
参天制药株式会社 |
用于与血管通透性有关的疾病或病症的制剂和方法
|
US20070293807A1
(en)
*
|
2006-05-01 |
2007-12-20 |
Lynch Mary G |
Dual drainage pathway shunt device and method for treating glaucoma
|
CN101484088A
(zh)
*
|
2006-05-04 |
2009-07-15 |
赫伯特·考夫曼 |
眼治疗剂的给药方法、装置和系统
|
WO2008061043A2
(en)
|
2006-11-10 |
2008-05-22 |
Glaukos Corporation |
Uveoscleral shunt and methods for implanting same
|
WO2008063639A2
(en)
*
|
2006-11-21 |
2008-05-29 |
Massachusetts Eye And Ear Infirmary |
Compositions and methods for preserving cells of the eye
|
WO2008076544A2
(en)
*
|
2006-12-18 |
2008-06-26 |
Alcon Research, Ltd. |
Devices and methods for ophthalmic drug delivery
|
DE102007024642A1
(de)
|
2007-05-24 |
2008-11-27 |
Eyesense Ag |
Hydrogel-Implantat für Sensorik von Metaboliten am Auge
|
MX2010006840A
(es)
|
2007-12-20 |
2010-08-12 |
Univ Southern California |
Aparato y métodos para suministrar agentes terapeuticos.
|
EP2240220B1
(en)
*
|
2008-01-03 |
2016-04-13 |
University Of Southern California |
Implantable drug-delivery devices, and apparatus for refilling the devices
|
US9849238B2
(en)
|
2008-05-08 |
2017-12-26 |
Minipumps, Llc |
Drug-delivery pump with intelligent control
|
CN103349803B
(zh)
*
|
2008-05-08 |
2016-12-28 |
迷你泵有限责任公司 |
可植入药物传送装置与用于填充该装置的设备和方法
|
US8231608B2
(en)
*
|
2008-05-08 |
2012-07-31 |
Minipumps, Llc |
Drug-delivery pumps and methods of manufacture
|
MX2010012213A
(es)
*
|
2008-05-08 |
2011-05-03 |
Minipumps Llc |
Bombas implantables y cánulas para las mismas.
|
US10064819B2
(en)
|
2008-05-12 |
2018-09-04 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
US9095404B2
(en)
|
2008-05-12 |
2015-08-04 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
US9877973B2
(en)
|
2008-05-12 |
2018-01-30 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
EP2276439A4
(en)
|
2008-05-12 |
2013-11-27 |
Univ Utah Res Found |
INTRAOCULAR DRUG DELIVERY DEVICE AND ASSOCIATED METHODS
|
WO2010056677A1
(en)
|
2008-11-12 |
2010-05-20 |
Duke University |
Methods of inhibiting cancer cell growth with hdac inhibitors and methods of screening for hdac10 inhibitors
|
AU2010208046B2
(en)
|
2009-01-29 |
2014-10-02 |
Forsight Vision4, Inc. |
Posterior segment drug delivery
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
US8372036B2
(en)
|
2009-05-06 |
2013-02-12 |
Alcon Research, Ltd. |
Multi-layer heat assembly for a drug delivery device
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
EP2437684B1
(en)
|
2009-06-03 |
2022-06-15 |
ForSight Vision5, Inc. |
Anterior segment drug delivery
|
IN2012DN00352A
(ja)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
AU2010284216B2
(en)
|
2009-08-18 |
2015-10-15 |
Minipumps, Llc |
Electrolytic drug-delivery pump with adaptive control
|
WO2011039648A1
(en)
|
2009-09-30 |
2011-04-07 |
Glaxo Wellcome Manufacturing Pte Ltd. |
Methods of administration and treatment
|
US8177747B2
(en)
|
2009-12-22 |
2012-05-15 |
Alcon Research, Ltd. |
Method and apparatus for drug delivery
|
WO2013022801A1
(en)
|
2011-08-05 |
2013-02-14 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
US20130137642A1
(en)
|
2010-04-23 |
2013-05-30 |
Demetrios Vavvas |
Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells
|
EP2571526B1
(en)
|
2010-05-17 |
2019-03-13 |
Novaer Holdings, Inc. |
Drug delivery devices for delivery of ocular therapeutic agents
|
CN103153316B
(zh)
|
2010-08-05 |
2015-08-19 |
弗赛特影像4股份有限公司 |
组合药物递送方法和设备
|
EP2600812B1
(en)
|
2010-08-05 |
2021-09-22 |
ForSight Vision4, Inc. |
Apparatus to treat an eye
|
PT2600930T
(pt)
|
2010-08-05 |
2021-03-22 |
Forsight Vision4 Inc |
Aparelho injetor e método para distribuição de fármacos
|
US8689439B2
(en)
|
2010-08-06 |
2014-04-08 |
Abbott Laboratories |
Method for forming a tube for use with a pump delivery system
|
US8377000B2
(en)
|
2010-10-01 |
2013-02-19 |
Abbott Laboratories |
Enteral feeding apparatus having a feeding set
|
US8377001B2
(en)
|
2010-10-01 |
2013-02-19 |
Abbott Laboratories |
Feeding set for a peristaltic pump system
|
US20120109054A1
(en)
*
|
2010-10-29 |
2012-05-03 |
Vista Scientific Llc |
Devices with an erodible surface for delivering at least one active agent to tissue over a prolonged period of time
|
US20140024598A1
(en)
|
2010-11-01 |
2014-01-23 |
Demetrios Vavvas |
Methods and compositions for preserving retinal ganglion cells
|
WO2012068549A2
(en)
|
2010-11-19 |
2012-05-24 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
US9919099B2
(en)
|
2011-03-14 |
2018-03-20 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
US9603997B2
(en)
|
2011-03-14 |
2017-03-28 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
US10286146B2
(en)
|
2011-03-14 |
2019-05-14 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
EP2720539B1
(en)
|
2011-06-14 |
2018-10-24 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
WO2013003467A2
(en)
|
2011-06-27 |
2013-01-03 |
Massachusetts Eye And Ear Infirmary |
Methods for treating ocular inflammatory disorders
|
EP2726016B1
(en)
|
2011-06-28 |
2023-07-19 |
ForSight Vision4, Inc. |
An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
|
WO2013025840A1
(en)
|
2011-08-15 |
2013-02-21 |
Massachusetts Eye And Ear Infirmary |
Methods for preserving photoreceptor cell viability following retinal detachment
|
WO2013040238A2
(en)
|
2011-09-13 |
2013-03-21 |
Vista Scientific Llc |
Sustained release ocular drug delivery devices and methods of manufacture
|
US11363951B2
(en)
|
2011-09-13 |
2022-06-21 |
Glaukos Corporation |
Intraocular physiological sensor
|
KR102192603B1
(ko)
|
2011-09-14 |
2020-12-17 |
포사이트 비젼5, 인크. |
안내 삽입물 장치 및 방법
|
LT2755600T
(lt)
|
2011-09-16 |
2021-04-26 |
Forsight Vision4, Inc. |
Skysčio pakeitimo aparatas
|
WO2013058809A1
(en)
|
2011-10-19 |
2013-04-25 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
JP6254090B2
(ja)
|
2011-10-21 |
2017-12-27 |
マサチューセッツ・アイ・アンド・イア・インファーマリー |
軸索再生および神経機能を促進するための方法および組成物
|
US9353063B2
(en)
|
2011-11-30 |
2016-05-31 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
CA2862746A1
(en)
|
2011-12-01 |
2013-06-06 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
ES2752028T3
(es)
|
2012-10-26 |
2020-04-02 |
Forsight Vision5 Inc |
Sistema oftálmico para la liberación sostenida del fármaco en el ojo
|
US9730638B2
(en)
|
2013-03-13 |
2017-08-15 |
Glaukos Corporation |
Intraocular physiological sensor
|
WO2014152959A1
(en)
|
2013-03-14 |
2014-09-25 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
US9592151B2
(en)
|
2013-03-15 |
2017-03-14 |
Glaukos Corporation |
Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye
|
US9526654B2
(en)
|
2013-03-28 |
2016-12-27 |
Forsight Vision4, Inc. |
Ophthalmic implant for delivering therapeutic substances
|
EP2991621B1
(en)
*
|
2013-05-02 |
2020-12-09 |
Retina Foundation of the Southwest |
Two-layer ocular implant
|
CN106459995B
(zh)
|
2013-11-07 |
2020-02-21 |
爱迪塔斯医药有限公司 |
使用统治型gRNA的CRISPR相关方法和组合物
|
EP3089748A4
(en)
|
2014-01-02 |
2017-09-27 |
Massachusetts Eye & Ear Infirmary |
Treating ocular neovascularization
|
US11028388B2
(en)
|
2014-03-05 |
2021-06-08 |
Editas Medicine, Inc. |
CRISPR/Cas-related methods and compositions for treating Usher syndrome and retinitis pigmentosa
|
US11339437B2
(en)
|
2014-03-10 |
2022-05-24 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
DK3116997T3
(da)
|
2014-03-10 |
2019-08-19 |
Editas Medicine Inc |
Crispr/cas-relaterede fremgangsmåder og sammensætninger til behandling af lebers kongenitale amaurose 10 (lca10)
|
US11141493B2
(en)
|
2014-03-10 |
2021-10-12 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
WO2015184173A1
(en)
|
2014-05-29 |
2015-12-03 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
EP3679908A1
(en)
|
2014-07-15 |
2020-07-15 |
ForSight Vision4, Inc. |
Ocular implant delivery device
|
US9474756B2
(en)
|
2014-08-08 |
2016-10-25 |
Forsight Vision4, Inc. |
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
|
BR112017009660A2
(pt)
|
2014-11-10 |
2017-12-19 |
Forsight Vision4 Inc |
dispositivos de administração de fármacos expansíveis e métodos de utilização
|
WO2016168141A1
(en)
|
2015-04-13 |
2016-10-20 |
Forsight Vision5, Inc. |
Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
|
US10010502B2
(en)
|
2015-05-19 |
2018-07-03 |
Amorphex Therapeutics Llc |
Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation
|
US11925578B2
(en)
|
2015-09-02 |
2024-03-12 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
WO2017053885A1
(en)
|
2015-09-25 |
2017-03-30 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
WO2017075475A1
(en)
|
2015-10-30 |
2017-05-04 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating herpes simplex virus
|
EP3377009B1
(en)
|
2015-11-20 |
2020-10-28 |
ForSight Vision4, Inc. |
Porous structures for extended release drug delivery devices
|
CN105997338B
(zh)
*
|
2016-03-09 |
2019-04-26 |
泰山医学院 |
经玻璃体纳米材料给药系统
|
JP7009384B2
(ja)
|
2016-04-05 |
2022-01-25 |
フォーサイト・ビジョン フォー・インコーポレーテッド |
移植可能な眼薬送達デバイス
|
CN109937025B
(zh)
|
2016-04-20 |
2022-07-29 |
多斯医学公司 |
生物可吸收眼部药物的递送装置
|
CA3032822A1
(en)
|
2016-08-02 |
2018-02-08 |
Editas Medicine, Inc. |
Compositions and methods for treating cep290 associated disease
|
AU2017312499B2
(en)
|
2016-08-19 |
2023-02-02 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Selective estrogen-receptor modulators (SERMs) confer protection against photoreceptor degeneration
|
WO2018081504A1
(en)
|
2016-10-28 |
2018-05-03 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating herpes simplex virus
|
CN110582286B
(zh)
|
2017-05-05 |
2024-01-30 |
联邦高等教育系统匹兹堡大学 |
基质结合囊泡(mbv)的眼部应用
|
PE20200743A1
(es)
|
2017-06-30 |
2020-07-24 |
Univ California |
Composiciones y metodos para modular el crecimiento del cabello
|
JP7314155B2
(ja)
|
2017-11-21 |
2023-07-25 |
フォーサイト・ビジョン4・インコーポレーテッド |
膨張可能ポート送達システムのための流体交換装置及びその使用方法
|
EP3758736B1
(en)
|
2018-03-02 |
2024-05-01 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Il-34 for use in a method of treating retinal inflammation and neurodegeneration
|
DE112019001996T5
(de)
*
|
2018-04-18 |
2020-12-31 |
Nikon Corporation |
Bildverarbeitungsverfahren, Programm und Bildverarbeitungsvorrichtung
|
US20220079899A1
(en)
*
|
2019-01-14 |
2022-03-17 |
The Regents Of The University Of California |
Compositions and methods for treating ocular conditions
|
AU2020227740A1
(en)
|
2019-02-25 |
2021-10-07 |
Editas Medicine, Inc. |
CRISPR/RNA-guided nuclease-related methods and compositions for treating RHO-associated autosomal-dominant retinitis pigmentosa (adRP)
|
JP2023510186A
(ja)
|
2020-01-17 |
2023-03-13 |
ザ ユナイテッド ステイツ オブ アメリカ アズ リプリゼンテッド バイ ザ セクレタリー、デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
Crx常染色体優性網膜症の処置のための遺伝子治療
|
JP2023532134A
(ja)
|
2020-07-02 |
2023-07-26 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
網膜変性の処置において使用するための環式化合物
|
WO2022221741A1
(en)
|
2021-04-16 |
2022-10-20 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease-related methods and compositions for treating rho-associated autosomal-dominant retinitis pigmentosa (adrp)
|